Home » Newsletters » BioWorld Asia

BioWorld Asia

Feb. 17, 1999

View Archived Issues

PowderJect, Ares-Serono Enter $100M Deal For Dry Vaccines

British Biotech's Marimastat Fails In Pivotal Cancer Study

Genetically Modified Milk Could Be Next On Shelves

Biota's Influenza Drug Wins Pair Of Approvals

Genset Reports Highest Quarterly Loss Of Year

European Parliament Calls For Amended GMO Rules

Cerep Revenues Hit Slump After Several Contracts End

EU Backs Biosafety Protocol, Warns Of 'Extreme Positions'

GMO Soya Crops Will Outdo Other Variety, Says Professor

Trinity Biotech's EPS Up 67 Percent For Year

Virax Shares Valued Higher After Patents

Monsanto's GMO Cotton Plan Still Stymied By EU

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...